ESPLACSP 20685156published on Contractació pública (Catalunya)
Machine translation. The official title is Servicio de fabricación de dos (2) lotes de Banco Celular Maestro de Células Mesenquimales derivadas de Sangre Menstrual (BCM-MenSC) bajo cumplimiento estricto de las Normas de Correcta Fabricación (NCF), y su conservación.
Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), based in Spain, has launched a tender for engineering and consulting. The contract is estimated at €38,300. The whole job goes out as a single contract, so you need to be able to deliver all of it, either on your own or together with partners.
All bid documents must be written in Spanish and must arrive no later than 29 Oct 2026, 13:00.
Written from the facts of the notice. The official notice is the only binding text.
Their latest award was a €390,300 contract (“Adquisición del medicamento Skilarence, fabricación de placebo, acondicionamien…”), which went to Alcura Health España S.a., the only bidder. At €38,300, this tender sits well below the typical €298,000 for this trade nationally, which gives smaller firms a better chance than on most contracts of its kind.
We base these figures on the award notices we collect: every one we hold for this buyer, plus the last twelve months of awards in this trade across the country.
Do not lose this contract over a missing document. GroundedBid reads the tender documents and lists what the buyer asks of you, each line with the page it comes from.
A paid service provided by tender.zone.Institut d'Investigació Biomèdica de Bellvitge (IDIBELL)PLACSP 20685192
In Aug 2024 a contract of this buyer went to Alcura Health España S.a. for €390,300. Only 1 companies applied. This time yours can be one of them.
Gerencia de Serveis i Obres Municipals Pedreguer, S.L.PLACSP 20715802
Gobierno Vasco-Dirección de Gestión EconómicaPLACSP 20751337
Tecnologías y Servicios Agrarios S.A., MadridPLACSP 20757723
SIMAP: This is not an official publication. The data published on www.simap.ch are authoritative. SIMAP data use is subject to its terms.